🇺🇸 FDA

P0 · Therapeutic area intelligence

Infectious disease patent intelligence

Antiviral, antibacterial, and vaccine-related pharmaceutical patents.

Patents
1,469

Quick answer

1,469 US pharmaceutical patents in our index match Infectious disease title keywords (A61K/A61P). Cross-link to related drug therapeutic-area hubs and company patent portfolios for full IP context.

  1. US 9598454

    Mannose derivatives for treating bacterial infections

    Vertex Pharmaceuticals Incorporated · Granted Tue Mar 21 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 9592271

    Angiopoietin-based interventions for treating cerebral malaria

    REGENERON PHARMACEUTICALS, INC. · Granted Tue Mar 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 9593108

    Compounds and methods for antiviral treatment

    PTC THERAPEUTICS, INC. · Granted Tue Mar 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 9592221

    Antibacterial agents: aryl myxopyronin derivatives

    Provid Pharmaceuticals Inc. · Granted Tue Mar 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 9579333

    Inhibition of HIV infection through chemoprophyalxis

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Feb 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 9580428

    Compositions and methods for inhibiting viral polymerase

    BioCryst Pharmaceuticals, Inc. · Granted Tue Feb 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 9574243

    Compositions and methods for the treatment of influenza infection

    Lakewood Amedex, Inc. · Granted Tue Feb 21 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 9572873

    Method of inducing a T lymphocyte response using T-cell immunogens derived from anti-viral proteins

    The Regents of the University of California · Granted Tue Feb 21 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 9566352

    Methods and compositions for inhibiting viral entry into cells

    Sangamo Biosciences, Inc. · Granted Tue Feb 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 9568473

    Methods for detecting Ehrlichia infection

    The Board of Regents of the University of Texas System · Granted Tue Feb 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 9567592

    Method for expression of small antiviral RNA molecules with reduced cytotoxicity within a cell

    The Regents of the University of California · Granted Tue Feb 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 9566348

    Methods and compositions for the treatment of cancer and infectious disease using alpha(2) macroglobulin-antigenic molecule complexes

    University of Connecticut Health Center · Granted Tue Feb 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 9556237

    Antiviral rift valley fever virus peptides and methods of use

    The United States of America, as represented by the Secretary of the Army, on behalf of the U.S. Army Medical Research Institute of Infectious Diseases · Granted Tue Jan 31 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 9549905

    Treatment of inflammatory and infectious skin disorders

    The Regents of the University of California · Granted Tue Jan 24 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 19 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 9533014

    Synergistic bacterial compositions and methods of production and use thereof

    Seres Therapeutics, Inc. · Granted Tue Jan 03 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 9533990

    Inhibitors of secretion of hepatitis B virus antigens

    ARBUTUS BIOPHARMA CORPORATION · Granted Tue Jan 03 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 9534220

    Antisense antibacterial method and compound

    Sarepta Therapeutics, Inc. · Granted Tue Jan 03 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 9529005

    Modulating bacterial MAM polypeptides in pathogenic disease

    The Board of Regents of the University of Texas System · Granted Tue Dec 27 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 9526769

    Macrocylic oximyl hepatitis C protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Tue Dec 27 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 9521845

    Beta-lactones as antibacterial agents

    Ludwig-Maximilians-Universitat Munchen · Granted Tue Dec 20 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 9517224

    Methods of treating patients infected with HIV and HTLV

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Dec 13 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 08 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 9518090

    Compositions and methods for treating hepatitis B

    The Regents of the University of Colorado, a Body Corporate · Granted Tue Dec 13 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 08 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 9511038

    Methods of treating non-alcoholic steatohepatitis (NASH) using cysteamine products

    The Regents of the University of California · Granted Tue Dec 06 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 01 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 9504701

    Methods for treating viral infections using hydrogen sulfide donors

    The Board of Regents of the University of Texas System · Granted Tue Nov 29 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 24 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 9504688

    Methods and compositions for treating bacterial infection

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Nov 29 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 24 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 9505809

    Proteins with repetitive bacterial-IG-like (BIG) domains present in Leptospira species

    The Regents of the University of California · Granted Tue Nov 29 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 24 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 9499821

    Preventing or treating viral infection using an inhibitor of the LSD1 protein, a MAO inhibitor or an inhibitor of LSD1 and a MAO inhibitor

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Nov 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 9499595

    Development of influenza A antivirals

    The Board of Regents of the University of Texas System · Granted Tue Nov 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 9498529

    Methods for treating or preventing influenza virus infection by administering a serine protease inhibitor

    REGENERON PHARMACEUTICALS, INC. · Granted Tue Nov 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 9499583

    Antibacterial antisense oligonucleotide and method

    Sarepta Therapeutics, Inc. · Granted Tue Nov 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 9492480

    Iron oxide nanoparticles for use in treating non-infectious inflammatory disorders

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Tue Nov 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 9492415

    Methods of treating Parkinson's disease using viral vectors

    The Regents of the University of California · Granted Tue Nov 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 9486523

    Compositions and methods for treating and preventing Staphylococcus aureus infections

    XBIOTECH INC. · Granted Tue Nov 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 9486518

    Membrane proximal region of HIV GP41 anchored to the lipid layer of a virus-like particle vaccine

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Nov 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 9480669

    Method of destroying and preventing bacterial and fungal biofilm by amino acid infusion

    The Regents of the University of California · Granted Tue Nov 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 27 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 9475832

    Phosphonates with reduced toxicity for treatment of viral infections

    The Regents of the University of California · Granted Tue Oct 25 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 20 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 9474793

    Vaccines and methods for prevention and treatment of drug-resistant HIV-1 and hepatitis B virus

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Oct 25 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 20 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 9468624

    Small molecule antagonists of bacterial quorum-sensing receptors

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Tue Oct 18 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 13 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 9464132

    Nanoantibodies, binding Chlamydia trachomatis antigen, method for inhibition of infection induced by Chlamydia trachomatis

    OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTYU “WELDUP” · Granted Tue Oct 11 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 06 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 9453239

    Recombinant MVA viruses expressing clade A/G, clade B, and clade C modified HIV env, gag and pol genes

    The Government of the United States of America, as represented by the Secretary Department of Health and Human Services, National Institutes of Health · Granted Tue Sep 27 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 9453019

    Linked purine pterin HPPK inhibitors useful as antibacterial agents

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Sep 27 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 9446139

    Polymer-based compositions and conjugates of HIV entry inhibitors

    Nektar Therapeutics · Granted Tue Sep 20 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 9441041

    Use of antagonists of the interaction between HIV GP120 and α4β7 integrin

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Sep 13 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 08 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 9439979

    Epidermal growth factor receptor (EGFR) and methods of use in adenoviral-associated virus type 6 (AAV6) transduction

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Sep 13 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 08 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 9435804

    Detection, prevention, and treatment of anthrax and other infectious diseases

    BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE OF THE UNIVERSITY OF NEVADA, RENO · Granted Tue Sep 06 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 01 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 9427447

    Anti-viral pyrimidine nucleoside derivatives

    University College Cardiff Consultants Limited · Granted Tue Aug 30 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 9422347

    Algal produced malarial transmission blocking vaccines

    The Regents of the University of California · Granted Tue Aug 23 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 9416165

    Methods of inhibiting viral replication and improving T cell function employing soluble Tim-3 inhibitors

    The Regents of the University of California · Granted Tue Aug 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many Infectious disease patents are indexed?

1,469 patents match our Infectious disease classifier (title keywords in USPTO records).

Is this legal or medical advice?

No — patent intelligence is for professional reference. Verify expiration and FTO with qualified patent counsel and primary USPTO records.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.